Patent details
LUC00059 Product Name: Dupilumab et ses dérivés pharmaceutiquement acceptables (DUPIXENT)
Basic Information
- Publication number:
- LUC00059
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP097442925
- Legal Status:
- Inactive
- Application number:
- LUC00059
- First applicant's nationality:
- Procedural language:
- French
Paediatric Extension
- SPC Extension Filing Date:
- 11/04/2023
- SPC Extension Agent Name:
- OFFICE FREYLINGER S.A.
- SPC Extension Status:
- Granted
- SPC Extension Grant Date:
- 21/10/2024
- SPC Extension Rejection Date:
Marketing Authorization
- Marketing Authorization Number:
- EU/1/17/1229
- Marketing Authorization Type:
- Marketing Authorization Date:
- 28/09/2017
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 28/12/2017
- First Marketing Authorization date:
- 28/09/2017
- Grant date:
- 28/03/2018
- Activation date:
- Publication date:
- 03/01/2018
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 28/09/2032
- SPC Extension Expiration:
- 28/03/2033
- Rejection date:
- Withdrawal date:
Owner
- From:
- 28/12/2017
- Name:
- REGENERON PHARMACEUTICALS, INC.
- Address:
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY 10591, United States (US)
Agent
- Name:
- Office FREYLINGER S.A.
- From:
- 28/12/2017
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2018/03
- Publication date:
- 20/02/2018
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2018/05
- Publication date:
- 11/04/2018
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
3
- Bulletin Heading:
- SPCX1
- Bulletin edition number:
- 2023/06
- Publication date:
- 05/05/2023
- Description:
- Section G : Applications for extensions for pediatric use – I1E publication
4
- Bulletin Heading:
- SPCX2
- Bulletin edition number:
- 2024/13
- Publication date:
- 05/11/2024
- Description:
- Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication
Annual Fees
- Annual Fee Due Date:
- 31/10/2029
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 03/01/2018 | Publication | 1 |
| 28/12/2017 | Application Form | 4 |
| 28/03/2018 | Certificate | 1 |
| 11/04/2023 | Application Form | 3 |
| 11/04/2023 | Marketing authorization | 3 |
| 11/04/2023 | General Document | 2 |
| 11/04/2023 | Paediatric investigation plan | 1 |
| 11/04/2023 | Summary of the product caracteristics | 287 |
| 11/04/2023 | Outgoing Correspondence | 1 |
| 28/12/2017 | General Document | 68 |
| 03/01/2018 | Outgoing Correspondence | 1 |
| 28/12/2017 | General Document | 3 |
| 28/03/2018 | Publication | 1 |
| 28/12/2017 | General Document | 2 |
| 11/04/2023 | Publication | 1 |
| 21/10/2024 | Publication | 1 |
| 21/10/2024 | Certificate | 1 |
| 11/04/2023 | FNET_DC_FRONTPAGE | 1 |
| 22/10/2024 | Outgoing Correspondence | 1 |